Cargando…
The Impact of Genetic and Non-Genetic Factors on Warfarin Dose Prediction in MENA Region: A Systematic Review
BACKGROUND: Warfarin is the most commonly used oral anticoagulant for the treatment and prevention of thromboembolic disorders. Pharmacogenomics studies have shown that variants in CYP2C9 and VKORC1 genes are strongly and consistently associated with warfarin dose variability. Although different pop...
Autores principales: | Bader, Loulia Akram, Elewa, Hazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167425/ https://www.ncbi.nlm.nih.gov/pubmed/27992547 http://dx.doi.org/10.1371/journal.pone.0168732 |
Ejemplares similares
-
Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021) -
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
por: El Rouby, Nihal, et al.
Publicado: (2021) -
Effect of SAMe-TT(2)R(2) score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
por: Elewa, Hazem, et al.
Publicado: (2020) -
The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in
the MENA Region: A Systematic Review
por: Ali, Zainab, et al.
Publicado: (2019) -
The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients
por: Wattanachai, Nitsupa, et al.
Publicado: (2017)